Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS
- PMID: 36139649
- PMCID: PMC9496843
- DOI: 10.3390/cancers14184489
Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS
Abstract
The aim of the study was to examine the benefits of the joint use of repeat FNA (rFNA) and EU-TIRADS in category III nodules in relation to the kind of atypia: nuclear vs. architectural (denoted by AUS and FLUS respectively). The study included 127 AUS and 1739 FLUS nodules with a known category of EU-TIRADS. Repeat FNA was performed in 82 AUS and 934 FLUS nodules of which 57 and 515 were excised, respectively. AUS nodules had higher malignancy risk than FLUS nodules. EU-TIRADS showed higher accuracy for AUS nodules, the opposite to rFNA, that had higher accuracy for FLUS nodules. The combined criterion for AUS nodules (at least rFNA-V or EU-TIRADS-4) maximized sensitivity (92.3%) with acceptable specificity (70.0%); OR: 28.0. In the case of FLUS nodules, the combined criterion (rFNA-V or EU-TIRADS-5) maximized specificity (95.2%) with 57.7% sensitivity and a low percentage (13.9%) of positive nodules, OR: 27.0. In both types of nodules, the low risk category in EU-TIRADS and benign result of rFNA excluded cancer. Concluding, category III nodules with and without nuclear atypia differ in their risk of malignancy and, consequently, diagnostic criteria adopted for the evaluation of these nodules with rFNA and EU-TIRADS should be specific to AUS and FLUS nodules.
Keywords: AUS; Bethesda system; EU-TIRADS; FLUS; FNA; architectural atypia; cancer; nuclear atypia; thyroid.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
Similar articles
-
Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.Thyroid. 2012 May;22(5):468-75. doi: 10.1089/thy.2011.0185. Epub 2012 Feb 3. Thyroid. 2012. PMID: 22304417
-
Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.Front Endocrinol (Lausanne). 2023 May 29;14:1135196. doi: 10.3389/fendo.2023.1135196. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37313444 Free PMC article.
-
Approach to Bethesda system category III thyroid nodules according to US-risk stratification.Endocr J. 2022 Jan 28;69(1):67-74. doi: 10.1507/endocrj.EJ21-0300. Epub 2021 Aug 18. Endocr J. 2022. PMID: 34408101
-
Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18. Cytopathology. 2013. PMID: 23078633 Review.
-
Atypia of undetermined significance/follicular lesion of undetermined significance: Asian vs. non-Asian practice, and the Singapore experience.Gland Surg. 2020 Oct;9(5):1764-1787. doi: 10.21037/gs-20-555. Gland Surg. 2020. PMID: 33224854 Free PMC article. Review.
Cited by
-
The Role of "Critical" Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules.Medicina (Kaunas). 2023 Aug 17;59(8):1484. doi: 10.3390/medicina59081484. Medicina (Kaunas). 2023. PMID: 37629774 Free PMC article.
-
Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia.Cancers (Basel). 2023 Aug 27;15(17):4287. doi: 10.3390/cancers15174287. Cancers (Basel). 2023. PMID: 37686562 Free PMC article.
-
Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.Ultrasonography. 2024 Nov;43(6):395-406. doi: 10.14366/usg.24083. Epub 2024 Aug 5. Ultrasonography. 2024. PMID: 39397446 Free PMC article.
-
Diagnostic efficiency among Eu-/C-/ACR-TIRADS and S-Detect for thyroid nodules: a systematic review and network meta-analysis.Front Endocrinol (Lausanne). 2023 Aug 31;14:1227339. doi: 10.3389/fendo.2023.1227339. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720531 Free PMC article.
References
-
- Vuong H.G., Ngo H.T.T., Bychkov A., Jung C.K., Vu T.H., Lu K.B., Kakudo K., Kondo T. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis. Cancer Cytopathol. 2020;128:238–249. doi: 10.1002/cncy.22228. - DOI - PubMed
-
- Eisa N., Khan A., Akhter M., Fensterwald M., Saleem S., Fananapazir G., Campbell M.J. Both ultrasound features and nuclear atypia are associated with malignancy in thyroid nodules with atypia of undetermined significance. Ann. Surg. Oncol. 2018;25:3913–3918. doi: 10.1245/s10434-018-6826-6. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources